FDA Clears Oral Appliance to Treat Moderate to Severe Sleep Apnea in Children
The oral appliance is now approved to treat moderate to severe OSA and reduce snoring in children aged 6 to 17.
The oral appliance is now approved to treat moderate to severe OSA and reduce snoring in children aged 6 to 17.
A recently presented abstract on obstructive sleep apnea therapies has results that may surprise you.
Its focus on staff advancement, integrated ventilation monitoring, and a new obstructive sleep apnea program has helped make the Vanderbilt Respiratory Care Department one of the best in the nation.
Twelve years after the launch of RT Magazine, the publishers of RT are set to debut “Sleep Review, The Journal for Sleep Specialists.”
Read MoreThe number of SIDS deaths decreased by 38% between 1992 and 1996 as a result of parents following the advice of their pediatrician and placing babies on their back instead of their stomach to sleep.
Read More